ImmunoPrecise Antibodies Ltd. Files 6-K with Press Release
Ticker: HYFT · Form: 6-K · Filed: Mar 12, 2025 · CIK: 1715925
Sentiment: neutral
Topics: filing, sec, press-release
TL;DR
IPA files 6-K, incorporating March 12 press release into existing S-8 and F-3 filings.
AI Summary
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on March 12, 2025, incorporating a press release dated March 12, 2025, as Exhibit 99.1. This filing is incorporated by reference into several of the company's existing registration statements, including Form S-8 (File No. 333-256730) and Form F-3 (File Nos. 333-273197 and 333-281312).
Why It Matters
This filing indicates the company is providing updated information or material events to the SEC, which could impact investor understanding of its current status and ongoing corporate activities.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that incorporates a press release and updates existing registration statements, with no immediate indication of significant new risks.
Key Numbers
- 001-39530 — Commission File Number (Identifies the company's SEC filing series.)
Key Players & Entities
- ImmunoPrecise Antibodies Ltd. (company) — Registrant
- March 12, 2025 (date) — Press Release Date
- 333-256730 (document_id) — Form S-8 File Number
- 333-273197 (document_id) — Form F-3 File Number
- 333-281312 (document_id) — Form F-3 File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information that ImmunoPrecise Antibodies Ltd. has made or will make available to its security holders, specifically by incorporating a press release dated March 12, 2025.
Which registration statements does this filing incorporate by reference?
This filing incorporates Exhibit 99.1 into the Registration Statement on Form S-8 (File No. 333-256730) and Registration Statements on Form F-3 (File Nos. 333-273197 and 333-281312).
What is the filing date of this Form 6-K?
The filing date is March 12, 2025.
What is the SIC code for ImmunoPrecise Antibodies Ltd.?
The Standard Industrial Classification (SIC) code for ImmunoPrecise Antibodies Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Where is ImmunoPrecise Antibodies Ltd.'s principal executive office located?
The principal executive office is located at Industrious, 823 Congress Ave, Suite 300, Austin, Texas 78701.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 12, 2025 regarding ImmunoPrecise Antibodies Ltd. (HYFT).